Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study
ConclusionsPrevalence of severe side effects in a ‘real world’ population of PM women receiving adjuvant BPs is low and these drugs are generally well accepted and tolerated by patients.
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Heartburn | HER2 | Oral Cancer | Orthopaedics | Osteoporosis | Study | Toxicology | Women